Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
MXMaxCyte, Inc. logo

MaxCyte, Inc. (MXCT)

NASDAQ · Currency in USD
$1.40 ▼ -0.03 (-2.10%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.40 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$1.43
Open
$1.43
Day's Range
$1.36 – $1.43
52 Week Range
$0.64 – $1.81
Volume
757,456
Avg. Volume
1,060,098
Market Cap
$144.49M
Beta (5Y Monthly)
1.49
PE Ratio (TTM)
--
EPS (TTM)
-$0.33
Earnings Date
Nov 10, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$6.00

Profile: MaxCyte, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
91
CEO
Maher Masoud

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols.

Earnings

Next report: Tue, Nov 10, 2026
EPS estimate -$0.08 · Revenue est. $7.39M
DateEst.Actual
Aug 12, 2026-$0.09-$0.08Beat
May 12, 2026-$0.10-$0.04Beat
Mar 24, 2026-$0.08-$0.06Beat
Nov 12, 2025-$0.11-$0.12Miss
Aug 6, 2025-$0.10-$0.12Miss
May 7, 2025-$0.10-$0.10Beat

Analyst view

Consensus price target
$6.00 ▲ +328.6%
Range $6.00 – $6.00
Rating: Buy
Buy 67% · Hold 33% · Sell 0%

Get free alerts on MXCT and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.